GERMANY: PHARMACEUTICAL INVESTMENT BY BRAUN
Article Abstract:
The German Melsungen-based company B. Braun Melsungen AG is spending DM 300mn on the construction of a new pharmaceutical plant in Melsungen. Construction start is scheduled for spring 2002. The project will create about 300 new jobs. Within a job security package, the 4,000 or so staff have committed themselves to 520 hours of overtime over a 5-year period.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
US: NOVARTIS INVESTING IN EAST HANOVER
Article Abstract:
Novartis Pharmaceuticals Corp., which is concentrating its activities in New Jersey at its headquarters in East Hanover, is selling its plant in Summit to Schering-Plough. Novartis is to make investments of US$ 100mn in expanding infrastructure and research and development capacities at East Hanover by 2003.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
SWITZERLAND/US: WYETH-AYERST DRUG TO ARES-SERONO
Article Abstract:
Wyeth-Ayerst Pharmaceuticals, a subsidiary of AHP, has sold the exclusive marketing rights for Crinone to Ares-Serono SA of Geneva, Switzerland. Crinone, a vaginal progesterone gel against infertility that was originally developed by Columbia Laboratories, has been cleared for the US, UK and German markets.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: GERMANY: SCHERING IN CONTRAST AGENT DEAL. GERMANY/SWITZERLAND: WAGNER AUTOMOBIL TO EMS. GERMANY/US: GRAPHICAL FILMS BY NESCHEN, GBC
- Abstracts: GERMANY: SCHERING IN CONTRAST AGENT DEAL. GERMANY: NEW TEST FOR THROMBOSIS THERAPY MONITORING
- Abstracts: SWITZERLAND/JAPAN: NATURAL COSMETICS BY WELEDA. SWITZERLAND/GERMANY: WELEDA RESULTS FOR 1998. SWITZERLAND: 1997/98 RECORD YEAR FOR FIRMENICH
- Abstracts: Galactoarabinan: An Exfoliant for Human Skin. Aloe vera quality control. Evaluating toothpaste sweetening
- Abstracts: Coty to purchase Revlon. Understanding "mild" cosmetic products. Perfumers need time and teamwork for optimal results